Tudorza Pressair (TU-door-za, aclidinium), a new inhaled anticholinergic for COPD

Reps will promote Tudorza Pressair (TU-door-za, aclidinium), a new inhaled anticholinergic for COPD.

It's an alternative to tiotropium (Spiriva) for maintenance treatment of COPD bronchospasm.

Aclidinium is a bronchodilator comparable to tiotropium.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote